HomeVVY • AMS
add
Vivoryon Therapeutics NV
Previous close
€0.65
Day range
€0.65 - €0.74
Year range
€0.41 - €19.56
Market cap
18.35M EUR
Avg Volume
457.19K
P/E ratio
-
Dividend yield
-
Primary exchange
AMS
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.35M | -20.07% |
Net income | -5.36M | 14.84% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.33M | 20.11% |
Effective tax rate | 0.42% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 38.58M | 58.23% |
Total assets | 45.36M | 42.88% |
Total liabilities | 3.82M | -41.27% |
Total equity | 41.53M | — |
Shares outstanding | 25.96M | — |
Price to book | 0.40 | — |
Return on assets | -29.47% | — |
Return on capital | -32.11% | — |
Cash Flow
Net change in cash
(EUR) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -5.36M | 14.84% |
Cash from operations | -10.14M | -98.13% |
Cash from investing | -4.50K | -350.00% |
Cash from financing | 11.70M | 19.50% |
Net change in cash | 1.51M | -68.86% |
Free cash flow | -2.16M | 40.42% |
About
Founded
1997
Website
Employees
15